Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut; and.
J Nucl Med. 2013 Dec;54(12):2104-10. doi: 10.2967/jnumed.112.115105. Epub 2013 Oct 7.
Peripheral vascular disease (PVD) is an atherosclerotic disease affecting the lower extremities, resulting in skeletal muscle ischemia, intermittent claudication, and, in more severe stages of disease, limb amputation and death. The evaluation of therapy in this patient population can be challenging, as the standard clinical indices are insensitive to assessment of regional alterations in skeletal muscle physiology. Radiotracer imaging of the lower extremities with techniques such as PET and SPECT can provide a noninvasive quantitative technique for the evaluation of the pathophysiology associated with PVD and may complement clinical indices and other imaging approaches. This review discusses the progress in radiotracer-based evaluation of PVD and highlights recent advancements in molecular imaging with potential for clinical application.
外周血管疾病(PVD)是一种累及下肢的动脉粥样硬化性疾病,可导致骨骼肌缺血、间歇性跛行,在疾病更严重的阶段,还会导致肢体截肢和死亡。评估此类患者群体的治疗效果具有一定挑战性,因为标准的临床指标不能敏感地反映骨骼肌生理学的区域性变化。采用 PET 和 SPECT 等技术对下肢进行放射性示踪剂成像,可以提供一种非侵入性的定量技术,用于评估与 PVD 相关的病理生理学,并可能补充临床指标和其他影像学方法。本文讨论了基于放射性示踪剂的 PVD 评估方法的进展,并重点介绍了具有潜在临床应用前景的分子影像学方面的最新进展。